Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

AstraZeneca claims fumarate salts of ErbB kinase inhibitors for cancer therapy

Jan. 12, 2010

FDA grants orphan drug designation to Clavis's CP-4126 for pancreatic cancer

Jan. 12, 2010

FDA grants fast track designation to Sopherion Therapeutics' Myocet in breast cancer

Jan. 12, 2010

Novel ER alpha and beta ligands discovered by Czech scientists

Jan. 12, 2010

Takeda claims novel protein kinase inhibitors for cancer therapy

Jan. 11, 2010

National Health Research Institutes identify aurora A kinase inhibitors for cancer therapy

Jan. 11, 2010

Joyant Pharmaceuticals identifies novel antineoplastic agents

Jan. 11, 2010

Agennix discloses Plk-1 inhibitors for cancer therapy

Jan. 11, 2010

Access Pharmaceuticals completes ProLindac monotherapy trial

Jan. 11, 2010

Lilly presents inhibitors of hedgehog signaling for cancer therapy

Jan. 11, 2010